CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
research
Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice
Authors
Almog
DeBourcy
+27 more
Degner
Hawley
Hosmer
Janz
Klabunde
Klabunde
Lafata
Lantz
Leard
Ling
Ling
McQueen
McQueen
Meissner
Partin
Pignone
Powell
Ruffin
Schroy
Schroy
Smith
Steinwachs
U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S.
Vernon
Vernon
Vernon
Wolf
Publication date
15 May 2012
Publisher
'Wiley'
Doi
View
on
PubMed
Abstract
BACKGROUND: The purpose of this study was to identify factors associated with colorectal cancer (CRC) screening test preference and examine the association between test preference and test completed. METHODS: Patients (n = 1224) were 50‐70 years, at average CRC risk, and overdue for screening. Outcome variables were preference for fecal occult blood test (FOBT), colonoscopy (COL), sigmoidoscopy (SIG), or barium enema (BE), measured by telephone survey, and concordance between test preference and test completed assessed using medical records. RESULTS: Thirty‐five percent preferred FOBT, 41.1% COL, 12.7% SIG, and 5.7% BE. Preference for SIG or COL was associated with having a physician recommendation, greater screening readiness, test‐specific self‐efficacy, greater CRC worry, and perceived pros of screening. Preference for FOBT was associated with self‐efficacy for doing FOBT. Participants who preferred COL were more likely to complete COL compared with those who preferred another test. Of those screened, only 50% received their preferred test. Those not receiving their preferred test most often received COL (52%). CONCLUSIONS: Lack of concordance between patient preference and test completed suggests that patients' preferences are not well incorporated into screening discussions and test decisions, which could contribute to low screening uptake. Physicians should acknowledge patients' preferences when discussing test options and making recommendations, which may increase patients' receptivity to screening. Cancer 2011. © 2011 American Cancer Society. Lack of concordance between patient preference and test completed suggests that patients' preferences are not well incorporated into screening discussions and test decisions, which may hinder screening completion. Physicians should acknowledge patients' preferences when discussing test options and making recommendations, which may increase patients' receptivity to screening.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/91219/1/26551_ftp.pd
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1002%2Fcncr.26551
Last time updated on 03/01/2020
Deep Blue Documents
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:deepblue.lib.umich.edu:202...
Last time updated on 25/05/2012